Skip to main content
Home
  • ALL Specialities ALL Specialities
    Home
    Home

    Error message

    • Deprecated function: Return type of DatabaseStatementBase::execute($args = [], $options = []) should either be compatible with PDOStatement::execute(?array $params = null): bool, or the #[\ReturnTypeWillChange] attribute should be used to temporarily suppress the notice in require_once() (line 2246 of /var/www/webmd/apps/mdedge/htdocs/includes/database/database.inc).
    • Deprecated function: Return type of DatabaseStatementEmpty::current() should either be compatible with Iterator::current(): mixed, or the #[\ReturnTypeWillChange] attribute should be used to temporarily suppress the notice in require_once() (line 2348 of /var/www/webmd/apps/mdedge/htdocs/includes/database/database.inc).
    • Deprecated function: Return type of DatabaseStatementEmpty::next() should either be compatible with Iterator::next(): void, or the #[\ReturnTypeWillChange] attribute should be used to temporarily suppress the notice in require_once() (line 2348 of /var/www/webmd/apps/mdedge/htdocs/includes/database/database.inc).
    • Deprecated function: Return type of DatabaseStatementEmpty::key() should either be compatible with Iterator::key(): mixed, or the #[\ReturnTypeWillChange] attribute should be used to temporarily suppress the notice in require_once() (line 2348 of /var/www/webmd/apps/mdedge/htdocs/includes/database/database.inc).
    • Deprecated function: Return type of DatabaseStatementEmpty::valid() should either be compatible with Iterator::valid(): bool, or the #[\ReturnTypeWillChange] attribute should be used to temporarily suppress the notice in require_once() (line 2348 of /var/www/webmd/apps/mdedge/htdocs/includes/database/database.inc).
    • Deprecated function: Return type of DatabaseStatementEmpty::rewind() should either be compatible with Iterator::rewind(): void, or the #[\ReturnTypeWillChange] attribute should be used to temporarily suppress the notice in require_once() (line 2348 of /var/www/webmd/apps/mdedge/htdocs/includes/database/database.inc).

    Michele G. Sullivan

    News

    Colchicine reduces inflammatory markers associated with metabolic syndrome

    Author:
    Michele G. Sullivan
    Publish date: April 8, 2019

    Colchicine was linked to lower levels of inflammatory markers and improved fasting insulin levels and glucose effectiveness.

    • Read More

    News

    Deuterium-altered ruxolitinib may be an effective treatment for alopecia areata

    Author:
    Michele G. Sullivan
    Publish date: April 7, 2019

    WASHINGTON – About half of those who took 8 mg of CPT-543, a chemically altered form of ruxolitinib, twice a day for 24 weeks, regrew hair –by at...

    • Read More

    News

    Abatacept appears safe for RA patients with COPD

    Author:
    Michele G. Sullivan
    Publish date: April 5, 2019

    A large prescription database review found no significantly increased risks of COPD exacerbation, pneumonia, flu, or bronchitis.

    • Read More

    News

    Amyloid brain imaging changed clinical management in 60% of MCI and dementia patients

    Author:
    Michele G. Sullivan

    Results from IDEAS, a prospective imaging study, refined Alzheimer’s disease diagnoses in both amyloid-positive and amyloid-negative cases. Now it...

    • Read More

    News

    Corticosteroids: What is their place in pneumonia and sepsis?

    Author:
    Michele G. Sullivan
    Publish date: March 26, 2019

    Two experts drew on both personal experience and extant literature in the debate “Steroids for Pneumonia and Sepsis ... Do You Believe?”

    • Read More

    News

    Hospitalists can make a difference in disasters

    Author:
    Michele G. Sullivan
    Publish date: March 26, 2019

    When fire is eating entire neighborhoods, or a hurricane is smashing towns like toys, the hospitalist will...

    • Read More

    News

    Total plasma tau correlates with dementia onset, Alzheimer’s disease

    Author:
    Michele G. Sullivan

    It’s not the Holy Grail of a simple Alzheimer’s blood test for the clinic. But it could be a big benefit in the...

    • Read More

    News

    BTK inhibitor calms pemphigus vulgaris with low-dose steroids

    Author:
    Michele G. Sullivan
    Publish date: March 8, 2019

    WASHINGTON – PRN1008 blocks BTK receptors on B cells, thus forestalling the B-cell mediated inflammatory cascade.

    • Read More

    Opinion

    IV ketamine, intranasal esketamine likely to ‘happily coexist’

    Author:
    Michele G. Sullivan
    Publish date: March 6, 2019

    “Initially, not every psychiatrist will be able to offer esketamine ... and that’s probably okay.”

    • Read More

    News

    FDA approves intranasal esketamine for refractory major depressive disorder

    Author:
    Michele G. Sullivan
    Publish date: March 5, 2019

    Under the FDA-required REMS, prescribers must complete specific training; the drug must be adminstered in office to allow for patient monitoring...

    • Read More

    News

    Bermekimab reduces lesions, cuts pain in patients with hidradenitis suppurativa

    Author:
    Michele G. Sullivan
    Publish date: March 3, 2019

    WASHINGTON – The human monoclonal antibody is the first to target interleukin-1 alpha in the disorder.

    • Read More

    News

    Many common dermatologic drugs can be safely used during pregnancy

    Author:
    Michele G. Sullivan
    Publish date: March 3, 2019

    WASHINGTON – With some caution, it’s possible to continue agents for psoriasis, atopic dermatitis, and pemphigus.

    • Read More

    News

    Texting improves postpregnancy hypertension monitoring in black women

    Author:
    Michele G. Sullivan
    Publish date: March 2, 2019

    LAS VEGAS – Compared with an office visit, the phone text system virtually eliminated the difference between the number of nonblack and black...

    • Read More

    News

    Selinexor hits FDA stumbling block

    Author:
    Michele G. Sullivan
    Publish date: February 26, 2019

    The Oncologic Drugs Advisory Committee expressed concern about the high rate of serious adverse events with the drug being developed to treat...

    • Read More

    News

    FDA: More safety data needed for 12 sunscreen active ingredients

    Author:
    Michele G. Sullivan
    Publish date: February 21, 2019

    Only two – titanium dioxide and zinc oxide – are generally recognized as safe and effective and not misbranded, officials said.

    • Read More

    Pages

    • « first
    • …
    • 2
    • 3
    • 4
    • 5
    • 6
    • 7
    • 8
    • 9
    • 10
    • …
    • last »

    Privacy Policy

    Terms of Use

    Editorial Policy

    Cookie Policy

    Ad Policy

    Medscape Customer Support

    Frequently Asked Questions

     

    Advertise with MDedge

    See more with MDedge! See our Other Publications

    MDedge: Keeping You Informed. Saving You Time.

    Copyright  © 2023 Frontline Medical Communications Inc., 283-299 Market Street, 2 Gateway Center, 4th Floor, Newark, NJ 07102. All rights reserved. Unauthorized use prohibited. The information provided is for educational purposes only. Use of this Web site is subject to the medical disclaimer.

    • All Specialties
      • MDedge Home
      • Cardiology
      • Clinician Reviews
      • Dermatology
      • Emergency Medicine
      • Endocrinology/Diabetes
      • Family Medicine
      • Federal Practitioner
      • Gastroenterology
      • Hematology/Oncology
      • Infectious Disease
      • Internal Medicine
      • Neurology
      • Obstetrics And Gynecology
      • Pediatrics
      • Psychiatry
      • Pulmonology
      • Rheumatology
      • Surgery
    • MDedge Home
    • Cardiology
    • Clinician Reviews
    • Dermatology
    • Emergency Medicine
    • Endocrinology/Diabetes
    • Family Medicine
    • Federal Practitioner
    • Gastroenterology
    • Hematology/Oncology
    • Infectious Disease
    • Internal Medicine
    • Neurology
    • Obstetrics And Gynecology
    • Pediatrics
    • Psychiatry
    • Pulmonology
    • Rheumatology
    • Surgery